TIGIT and breast carcinoma: Contrarily, the study by Zhang et al. revealed that TIGIT inhibition prevented NK cell exhaustion and inhibited tumor growth in several tumor-bearing models, including those of colon cancer, breast cancer, and fibrosarcoma [63].